These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3168389)

  • 1. Selective incorporation of iododeoxyuridine into DNA of hepatic metastases versus normal human liver.
    Speth PA; Kinsella TJ; Chang AE; Klecker RW; Belanger K; Collins JM
    Clin Pharmacol Ther; 1988 Oct; 44(4):369-75. PubMed ID: 3168389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iododeoxyuridine (IdUrd) incorporation into DNA of human hematopoietic cells, normal liver and hepatic metastases in man: as a radiosensitizer and as a marker for cell kinetic studies.
    Speth PA; Kinsella TJ; Chang AE; Klecker RW; Belanger K; Smith R; Rowland J; Cupp JE; Collins JM
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1247-50. PubMed ID: 2715075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.
    Lawrence TS; Davis MA; McKeever PE; Maybaum J; Stetson PL; Normolle DP; Ensminger WD
    Cancer Res; 1991 Aug; 51(15):3900-5. PubMed ID: 1830239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine.
    Cook JA; Glass J; Lebovics R; Bobo H; Pass H; DeLaney TF; Oldfield EH; Mitchell JB; Glatstein E; Goffman TE
    Cancer Res; 1992 Feb; 52(3):719-25. PubMed ID: 1732059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorodeoxyuridine modulation of the incorporation of iododeoxyuridine into DNA of granulocytes: a phase I and clinical pharmacological study.
    Speth PA; Kinsella TJ; Belanger K; Klecker RW; Smith R; Rowland JB; Collins JM
    Cancer Res; 1988 May; 48(10):2933-7. PubMed ID: 2965970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo modulation of iododeoxyuridine metabolism and incorporation into cellular DNA by 5'-amino-5'-deoxythymidine in normal mouse tissues and two human colon cancer xenografts.
    Kinsella TJ; Glennon MC; Kunugi KA; Lindstrom MJ
    Clin Cancer Res; 1996 Jun; 2(6):981-9. PubMed ID: 9816259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis.
    Morgan RJ; Newman EM; Doroshow JH; McGonigle K; Margolin K; Raschko J; Chow W; Somlo G; Leong L; Tetef M; Shibata S; Hamasaki V; Carroll M; Vasilev S; Akman S; Coluzzi P; Wagman L; Longmate J; Paz B; Yen Y; Klevecz R
    Cancer Res; 1998 Jul; 58(13):2793-800. PubMed ID: 9661893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of leucovorin on idoxuridine cytotoxicity and DNA incorporation.
    Greene RF; Collins JM
    Cancer Res; 1990 Oct; 50(20):6652-6. PubMed ID: 2208128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical modulation of 5-bromo-2'-deoxyuridine and 5-iodo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits.
    Stetson PL; Normolle DP; Knol JA; Johnson NJ; Yang ZM; Sakmar E; Prieskorn D; Terrio P; Knutsen CA; Ensminger WD
    J Natl Cancer Inst; 1991 Nov; 83(22):1659-67. PubMed ID: 1836238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study of intraarterial iododeoxyuridine in patients with colorectal liver metastases.
    Chang AE; Collins JM; Speth PA; Smith R; Rowland JB; Walton L; Begley MG; Glatstein E; Kinsella TJ
    J Clin Oncol; 1989 May; 7(5):662-8. PubMed ID: 2709091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer.
    Lawrence TS; Davis MA; Maybaum J; Mukhopadhyay SK; Stetson PL; Normolle DP; McKeever PE; Ensminger WD
    Cancer Res; 1992 Jul; 52(13):3698-704. PubMed ID: 1617642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iododeoxyuridine chemosensitization of cis-diamminedichloroplatinum(II) in human bladder cancer cells.
    Chi KH; Kunugi KA; Kinsella TJ
    Cancer Res; 1994 May; 54(10):2701-6. PubMed ID: 8168100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
    Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
    J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the metabolism and cytotoxicity of iododeoxyuridine by 5'-amino-5'-deoxythymidine.
    Fischer PH; Weddle MA; Mossie RD
    Mol Pharmacol; 1983 May; 23(3):709-16. PubMed ID: 6865913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization.
    Taverna P; Hwang HS; Schupp JE; Radivoyevitch T; Session NN; Reddy G; Zarling DA; Kinsella TJ
    Cancer Res; 2003 Feb; 63(4):838-46. PubMed ID: 12591735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
    Dupertuis YM; Vazquez M; Mach JP; De Tribolet N; Pichard C; Slosman DO; Buchegger F
    Cancer Res; 2001 Nov; 61(21):7971-7. PubMed ID: 11691821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of locally advanced cancer of the head and neck with 5'-iododeoxyuridine and hyperfractionated radiation therapy: measurement of cell labeling and thymidine replacement.
    Epstein AH; Lebovics RS; Goffman T; Teague D; Fuetsch ES; Glatstein E; Okunieff P; Cook JA
    J Natl Cancer Inst; 1994 Dec; 86(23):1775-80. PubMed ID: 7966416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical modulation of iododeoxyuridine by N6-[4-(morpholinosulfonyl)benzyl]-N6-methyl-2,6-diaminobenz[cd]indole glucuronate (AG-331) leading to enhanced cytotoxicity.
    Pressacco J; Mitrovski B; Hedley DW; Tsang R; Erlichman C
    Biochem Pharmacol; 1995 Jun; 50(1):55-60. PubMed ID: 7605345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo.
    Rodriguez R; Ritter MA; Fowler JF; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):105-13. PubMed ID: 8175417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of iododeoxyuridine into DNA of granulocytes in patients.
    Belanger K; Klecker RW; Rowland J; Kinsella TJ; Collins JM
    Cancer Res; 1986 Dec; 46(12 Pt 1):6509-12. PubMed ID: 3779659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.